2.92
+0.12(+4.29%)
Currency In USD
| Previous Close | 2.8 |
| Open | 2.8 |
| Day High | 2.93 |
| Day Low | 2.67 |
| 52-Week High | 1,194 |
| 52-Week Low | 2.21 |
| Volume | 164,344 |
| Average Volume | 420,562 |
| Market Cap | 2.21M |
| PE | -0.01 |
| EPS | -255.6 |
| Moving Average 50 Days | 4.68 |
| Moving Average 200 Days | 72.86 |
| Change | 0.12 |
If you invested $1000 in Conduit Pharmaceuticals Inc. (CDT) since IPO date, it would be worth $0.2 as of July 06, 2025 at a share price of $2.92. Whereas If you bought $1000 worth of Conduit Pharmaceuticals Inc. (CDT) shares 2 years ago, it would be worth $0.18 as of July 06, 2025 at a share price of $2.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health
GlobeNewswire Inc.
Jun 04, 2025 12:30 PM GMT
Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to capture commercial potential in the $15 billion animal health marketEvaluation of AZD5658 expands Condui
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
GlobeNewswire Inc.
May 22, 2025 12:30 PM GMT
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for comp
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
GlobeNewswire Inc.
May 21, 2025 12:30 PM GMT
Conduit regains compliance with Bid Price and Equity RequirementsCDT will continue to be listed and traded on The Nasdaq Stock Market NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: